T Cell Regulatory Circuitry: Antigen-Specific and TCR-Idiopeptide-Specific T Cell Interactions in EAE

References

• Von Boehmer H. Positive and negative selection of the αβ T cell repertoire in vivo. Curr. Opinion. Immunol. 1991; 3: 210
   Google Scholar
• Kumar V., Sercarz E. E. Regulation of autoimmunity. In. Current Opinion in Immunology 1991; 3: 888–895
   Google Scholar
• Gammon G., Sercarz E. E., Benichou G. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol. Today 1991; 12(6)193–195
   Google Scholar
• Gammon G., Sercarz E. How some T-cells escape tolerance induction. Nature 1989; 342: 183–185
   PubMedGoogle Scholar
• Cohen I. R., Young D. B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 1991; 12: 105–110
   PubMedGoogle Scholar
• Heber-Katz E., Acha-Orbea H. The V-region hypothesis: evidence from autoimmune encephalomyelitis. Immunol. Today 1989; 10: 164
   PubMedGoogle Scholar
• Sercarz E., Krzych U. The distinctive specificity of antigen-specific suppressor T cells. Immunol. Today 1991; 12: 111–118
   PubMedGoogle Scholar
• Pfeiffer C., Murray J., Madri J., Bottomly K. Selective activation of Th1- and Th2-like cells in vivo-Response to human collagen IV. Immunol. Rev. 1991; 123: 65–84
   PubMedGoogle Scholar
• Fujinami R. S., Oldstone M. B. A. Amino acid homology between the encephalitogenic site of MBP and virus; mechanisms of autoimmunity. Science 1985; 230: 1043–1045
   PubMed Web of Science ®Google Scholar
• Oldstone M. B. A. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819–820
   PubMed Web of Science ®Google Scholar
• McCarron R. M., Fallis R. J., McFarlin D. E. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 1990; 29: 73–79
   PubMed Web of Science ®Google Scholar
• Perry L. L., Barzaga-Gilbert E., Trotter J. L. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 1991; 33: 7–15
   PubMed Web of Science ®Google Scholar
• Lehmann P. V., Forsthuber T., Miller A., Sercarz E. E. Spreading of T-cell autoimmunity to cryptic determinants of an auto antigen. Nature 1992; 358: 155–157
   PubMed Web of Science ®Google Scholar
• Bhardwaj V., Kumar V., Geysen H. M., Sercarz E. E. Subjugation of dominant immunogenic determinants within a chimeric peptide. Europ. J. Immunol. 1992; 22(8)2009–2016
   Google Scholar
• Byers V. S., Sercarz E. E. The X-Y-Z scheme of immunocyte maturation IV The exhaustion of memory cells. J. Exp. Med. 1968; 127: 307–325
   Google Scholar
• Webb S., Morris C., Sprent J. Extrathymic tolerance of mature T cells. Clonal elimination as a consequence of immunity. Cell 1990; 63: 1249–1256
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Coffman R. L. Th1 and Th2 cells: Different pattern of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Eichmann K., Falk I., Rajewsky K. Recognition of idiotype interactions. Eur. J. Immunol. 1978; 8: 853–857
   Google Scholar
• Burns J., Rosenzweig A., Zweiman B., et al. Cell. Immunol. 1983; 81: 435–440
   PubMed Web of Science ®Google Scholar
• Burns J., Littlefield K., Gomez C., Kumar V. Assessment of antigenic determinants for the human T-cell response against myelin basic protein using overlapping synthetic peptides. J. Neuroimmunol. 1991; 31: 265–272
   Google Scholar
• Allegretta M., Nicklas J. A., Sriram S., Albertini R. J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990; 247: 718–721
   PubMed Web of Science ®Google Scholar
• Ohashi P. S., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305–317
   PubMed Web of Science ®Google Scholar
• Day M. J., Tse A. G. D., Puklavic M., Simmonds S. I., Mason D. W. Targetting autoantigen to B cells prevents the induction of a cell mediated autodisease in rats. J. Exp. Med. 1992; 175: 655–659
   PubMed Web of Science ®Google Scholar
• Ben-Nun A., Wekerle H., Cohen I. R. Vaccination against autoimmune encephalomyelitis using attenuated cells of a T lymphocyte line reactive against myelin basic protein. Nature 1981; 292: 60–61
   PubMed Web of Science ®Google Scholar
• Urban J. L., Kumar V., Kono D. H., Gomez C., Horvath S. I., Clayton J., Ando D. G., Sercarz E. E., Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 1988; 54: 577–592
   PubMed Web of Science ®Google Scholar
• Kumar V., Kono D. H., Urban J. L., Hood L. T-cell receptor repertoire and autoimmune diseases. Ann. Rev. Immunol. 1989; 7: 657–682
   PubMed Web of Science ®Google Scholar
• Sercarz E., Araneo B., Benjamin C. D., Harvey M., Metzger D., Miller A., Wicker L., Yowell R. The design of regulatory circuitry: predominant idiotypy and the idea of regulatory parsimony, C. Bona, H. Kohler. Ann. N. Y. Acad. Sci. Immune Networks 418, 1983; 198–205
   Google Scholar
• Acha-Orbea H., Steinman L., McDevitt H. O. T cell receptors in murine autoimmune diseases. Ann. Rev. Immunol. 1989; 7: 371–405
   PubMed Web of Science ®Google Scholar
• Nanda N. K., Apple R., Sercarz E. Limitations in plasticity of the T cell receptor repertoire. PNAS USA 1991; 88: 9503–9507
   Google Scholar
• Wraith D. C., Smilek D. E., Mitchell D. J., Steinman L., McDevitt H. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide mediated immunotherapy. Cell 1989; 59: 247–255
   PubMed Web of Science ®Google Scholar
• Lohse A. W., Mor E., Karin N., Cohen I. R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 1989; 244: 820–822
   PubMed Web of Science ®Google Scholar
• Vandenbark A. A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–544
   PubMed Web of Science ®Google Scholar
• Howell M. D., Winters S. T., Olee T., Powell H. C., Carlo D. J., Brostoff S. W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Jiang H., Sercarz E., Nitecki D., Pernis B. The problem of presentation of T cell receptor peptides by activated T cells. Annals of the New York Academy of Sciences 1991; 636: 28–32
   PubMedGoogle Scholar
• Koh D.-R., Fung-Leung W.-R., Ho A., Gray D., Acha-Orbea H., Mak T.-W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8+ mice. Science 1992; 256: 1210–1213
   PubMed Web of Science ®Google Scholar
• Jiang H., Zhang S., Pernis B. Role of CD8+ T cells in experimental allergic encephalomyelitis. Science 1992; 256: 1213–1215
   PubMed Web of Science ®Google Scholar
• Janeway C. A. Autoimmune disease: immunotherapy by peptides. Nature 1989; 341: 482–483
   Google Scholar